HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
David S Williams Selected Research
David S Williams Research Topics
Disease
13
Neoplasms (Cancer)
01/2021 - 12/2010
10
Colorectal Neoplasms (Colorectal Cancer)
11/2022 - 12/2010
7
Retinal Degeneration
10/2017 - 12/2003
7
Usher Syndromes (Usher Syndrome)
11/2011 - 01/2003
6
Blindness (Hysterical Blindness)
01/2015 - 12/2004
5
Retinitis Pigmentosa (Pigmentary Retinopathy)
03/2015 - 12/2003
4
Colonic Neoplasms (Colon Cancer)
01/2021 - 10/2010
4
Alzheimer Disease (Alzheimer's Disease)
02/2014 - 02/2005
4
Deafness (Deaf Mutism)
10/2011 - 12/2003
4
type 1B Usher syndrome
12/2009 - 05/2003
3
Neoplasm Metastasis (Metastasis)
11/2022 - 07/2014
3
Inflammation (Inflammations)
12/2021 - 01/2011
3
Ciliopathies
01/2020 - 10/2010
3
Microsatellite Instability
10/2018 - 12/2010
2
Disease Progression
11/2022 - 03/2015
2
Adenocarcinoma
01/2020 - 11/2011
2
Obesity
11/2019 - 12/2005
2
Hypoxia (Hypoxemia)
03/2019 - 03/2018
2
Thrombosis (Thrombus)
01/2018 - 01/2011
2
Macular Degeneration (Age-Related Maculopathy)
10/2017 - 08/2008
2
Nephrotic Syndrome (Syndrome, Nephrotic)
06/2014 - 12/2013
2
Deaf-Blind Disorders
07/2011 - 05/2003
2
Agenesis of Cerebellar Vermis
02/2010 - 06/2006
2
Nonsyndromic Deafness
12/2009 - 08/2009
1
Lung Diseases (Lung Disease)
01/2022
1
Silicosis
01/2022
1
Chediak-Higashi Syndrome
01/2022
1
Hypertension (High Blood Pressure)
01/2022
1
COVID-19
12/2021
1
Leukemia
01/2021
1
Stomach Neoplasms (Stomach Cancer)
01/2021
1
Biliary Tract Neoplasms (Biliary Tract Cancer)
11/2019
1
Malignant Mesothelioma
10/2018
1
Mesothelioma
10/2018
1
Necrosis
03/2018
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2018
1
Breast Neoplasms (Breast Cancer)
06/2017
1
Leber Congenital Amaurosis
01/2014
1
Hydatidiform Mole (Molar Pregnancy)
01/2014
Drug/Important Bio-Agent (IBA)
16
Retinaldehyde (Retinal)
IBA
01/2020 - 05/2003
14
Proteins (Proteins, Gene)
FDA Link
01/2022 - 05/2003
5
Myosin VIIa
IBA
10/2011 - 01/2003
4
Pharmaceutical Preparations
IBA
01/2021 - 01/2012
3
Biomarkers (Surrogate Marker)
IBA
01/2022 - 06/2017
3
GTP Phosphohydrolases (GTPases)
IBA
03/2015 - 03/2005
3
Carrier Proteins (Binding Protein)
IBA
05/2009 - 09/2005
2
Calcibiotic Root Canal Sealer
IBA
11/2022 - 04/2012
2
Transcription Factors (Transcription Factor)
IBA
11/2022 - 06/2006
2
DNA (Deoxyribonucleic Acid)
IBA
01/2022 - 10/2018
2
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
01/2022 - 03/2018
2
Interleukin-6 (Interleukin 6)
IBA
12/2021 - 01/2021
2
Cytokines
IBA
12/2021 - 01/2021
2
Phosphotransferases (Kinase)
IBA
01/2021 - 05/2009
2
Mucins
IBA
01/2020 - 03/2018
2
Lipids
IBA
12/2019 - 11/2019
2
Amyloid (Amyloid Fibrils)
IBA
02/2014 - 11/2008
2
Vaccines
IBA
12/2012 - 12/2010
2
Myosins (Myosin)
IBA
10/2011 - 09/2004
2
Antigens
IBA
12/2010 - 10/2010
2
Cadherins (E-Cadherin)
IBA
04/2004 - 12/2003
1
Chromatin
IBA
11/2022
1
Retinal Pigments (Pigments, Visual)
IBA
01/2022
1
Silicon Dioxide (Silica)
FDA Link
Generic
01/2022
1
Capecitabine (Xeloda)
FDA Link
01/2022
1
Bevacizumab (Avastin)
FDA Link
01/2022
1
Mitomycin (Mitomycin-C)
FDA Link
Generic
01/2022
1
Antiviral Agents (Antivirals)
IBA
12/2021
1
apolipoprotein A-I mimetic peptide 4F
IBA
12/2021
1
Messenger RNA (mRNA)
IBA
01/2021
1
tyrosine receptor (receptor, tyrosine)
IBA
01/2021
1
regorafenib
IBA
01/2021
1
Dexamethasone (Maxidex)
FDA Link
Generic
01/2021
1
Photosensitizing Agents (Photosensitizers)
IBA
01/2021
1
Interleukin-11 (Interleukin 11)
IBA
01/2021
1
Mitogen-Activated Protein Kinase Kinases (MEKs)
IBA
01/2021
1
Tumor Suppressor Protein p53
IBA
01/2020
1
Peroxisome Proliferator-Activated Receptors (PPAR)
IBA
11/2019
1
Reactive Oxygen Species (Oxygen Radicals)
IBA
03/2019
1
Oxygen (Dioxygen)
IBA
03/2019
1
Doxorubicin (Adriamycin)
FDA Link
Generic
01/2019
1
Ethylene Glycol (Monoethylene Glycol)
IBA
11/2018
1
polytrimethylene carbonate
IBA
11/2018
1
Promega
IBA
10/2018
1
Vimentin
IBA
03/2018
1
Indicators and Reagents (Reagents)
IBA
03/2018
1
parthenolide
IBA
01/2018
1
4- (4- dihexadecylaminostyryl)- N- methylpyridium (DiA)
IBA
06/2017
1
Biological Products
IBA
07/2014
1
Steroids
IBA
06/2014
1
Silver
IBA
01/2014
1
Formaldehyde (Formol)
FDA Link
01/2014
1
Paraffin
IBA
01/2014
1
Complementary DNA (cDNA)
IBA
01/2014
Therapy/Procedure
9
Therapeutics
12/2021 - 02/2008
3
Drug Therapy (Chemotherapy)
01/2022 - 07/2014
2
Transplantation
10/2017 - 03/2012
1
Adjuvant Chemotherapy
01/2020
1
Photochemotherapy (Photodynamic Therapy)
03/2019
1
Photothermal Therapy
01/2018
1
Lasers (Laser)
01/2018